Cargando…
SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
Autores principales: | Alexander, James L, Powell, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149174/ https://www.ncbi.nlm.nih.gov/pubmed/34048723 http://dx.doi.org/10.1016/S2468-1253(21)00184-9 |
Ejemplares similares
-
Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
por: Alexander, James L, et al.
Publicado: (2021) -
SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
por: Alexander, James L, et al.
Publicado: (2021) -
SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021) -
SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
por: Selim, Rania, et al.
Publicado: (2021) -
SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
por: Magro, Giuseppe
Publicado: (2020)